000			01407 a2200421 4500
005			20250513220200.0
264		0	_c20001018
008			200010s 0 0 eng d
022			_a0006-4971
040			_aNLM _beng _cNLM
100	1		_aWarkentin, T E
245	0	0	_aImpact of the patient population on the risk for heparin-induced thrombocytopenia. _h[electronic resource]
260			_bBlood _cSep 2000
300			_a1703-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnticoagulants _xadverse effects
650	0	4	_aBlood Platelets _xmetabolism
650	0	4	_aCardiac Surgical Procedures
650	0	4	_aCohort Studies
650	0	4	_aHeparin _xadverse effects
650	0	4	_aHeparin, Low-Molecular-Weight _xadverse effects
650	0	4	_aHumans
650	0	4	_aImmunoenzyme Techniques
650	0	4	_aImmunoglobulin G _xblood
650	0	4	_aOrthopedic Procedures
650	0	4	_aPlatelet Count _xdrug effects
650	0	4	_aPlatelet Factor 4 _ximmunology
650	0	4	_aPostoperative Complications _xchemically induced
650	0	4	_aRisk Factors
650	0	4	_aSerotonin _xmetabolism
650	0	4	_aThrombocytopenia _xchemically induced
700	1		_aSheppard, J A
700	1		_aHorsewood, P
700	1		_aSimpson, P J
700	1		_aMoore, J C
700	1		_aKelton, J G
773	0		_tBlood _gvol. 96 _gno. 5 _gp. 1703-8
999			_c10909416 _d10909416